Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Edwards Lifesciences
EW
$50B
| $1.9M | ﹤0.01% |
21,000
-8,000
| -28% | -$670K |
|
1977
Zura Bio
ZURA
$587M
| $1.9M | ﹤0.01% |
321,702
+8,402
| +3% | +$40K |
|
1978
Moog Inc Class B
MOG.B
$12B
| $1.9M | ﹤0.01% |
4,440
-160
| -3% | -$56.3K |
|
|
WHWK
1979
Whitehawk Therapeutics
WHWK
$250M
| $1.9M | ﹤0.01% |
413,822
-14,800
| -3% | -$61.6K |
|
1980
Harrow
HROW
$1.42B
| $1.89M | ﹤0.01% |
44,617
-39,962
| -47% | -$1.49M |
|
1981
Williams Companies
WMB
$92.8B
| $1.89M | ﹤0.01% |
+25,485
| New | +$1.88M |
|
1982
Valhi
VHI
$528M
| $1.89M | ﹤0.01% |
129,117
+700
| +0.5% | +$9.87K |
|
1983
Eton Pharmaceutcials
ETON
$1.7B
| $1.89M | ﹤0.01% |
52,300
-111,021
| -68% | -$3.26M |
|
1984
Kodak
KODK
$909M
| $1.89M | ﹤0.01% |
204,645
+177,055
| +642% | +$1.94M |
|
|
IONX
1985
Defiance Daily Target 2X Long IONQ ETF
IONX
$159M
| $1.89M | ﹤0.01% |
37,100
+7,100
| +24% | +$393K |
|
1986
Alto Neuroscience
ANRO
$1.41B
| $1.88M | ﹤0.01% |
71,399
-32,100
| -31% | -$742K |
|
1987
USCB Financial Holdings
USCB
$427M
| $1.88M | ﹤0.01% |
92,000
+800
| +0.9% | +$15.2K |
|
1988
Alector
ALEC
$276M
| $1.88M | ﹤0.01% |
935,166
-352,525
| -27% | -$755K |
|
1989
Aldeyra Therapeutics
ALDX
$92.9M
| $1.88M | ﹤0.01% |
882,000
+18,813
| +2% | +$32.3K |
|
1990
Security National Financial
SNFCA
$228M
| $1.88M | ﹤0.01% |
203,427
-9,975
| -5% | -$91.3K |
|
|
GRDN
1991
Guardian Pharmacy Services
GRDN
$2.69B
| $1.88M | ﹤0.01% |
44,798
-55,191
| -55% | -$2.14M |
|
1992
State Street SPDR Dow Jones REIT ETF
RWR
$1.84B
| $1.88M | ﹤0.01% |
+16,602
| New | +$1.82M |
|
|
NMG
1993
Nouveau Monde Graphite
NMG
$454M
| $1.86M | ﹤0.01% |
1,242,879
-190,144
| -13% | -$359K |
|
1994
Annovis Bio
ANVS
$55.4M
| $1.86M | ﹤0.01% |
1,002,200
+654,600
| +188% | +$1.27M |
|
1995
Putnam Focused Large Cap Value ETF
PVAL
$14.1B
| $1.86M | ﹤0.01% |
36,500
+7,400
| +25% | +$368K |
|
1996
Vanguard Industrials ETF
VIS
$7.99B
| $1.86M | ﹤0.01% |
5,160
-1,560
| -23% | -$529K |
|
1997
State Street Industrial Select Sector SPDR ETF
XLI
$32.1B
| $1.85M | ﹤0.01% |
10,000
-664,600
| -99% | -$115M |
|
1998
Kinsale Capital Group
KNSL
$8.37B
| $1.85M | ﹤0.01% |
+5,600
| New | +$1.8M |
|
1999
Stoneridge
SRI
$208M
| $1.85M | ﹤0.01% |
252,200
-32,700
| -11% | -$224K |
|
2000
Foghorn Therapeutics
FHTX
$287M
| $1.84M | ﹤0.01% |
377,936
-28,489
| -7% | -$126K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.